Clinical Trials
All Clinical Trials - Page 1 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07382375N/ANot Yet Recruiting
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Thymosin-Alpha-1
- NCT07430332Phase 2Not Yet Recruiting
GLP-1 RA for Stage 1 Type 1 Diabetes
Semaglutide
- NCT07850921Phase 1/Phase 2Not Yet Recruiting
REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult Participants
Gonadorelin
- NCT06303284Phase 1/Phase 2Not Yet Recruiting
PROactive HEALing in High-Risk Pelvic and Non-hip Lower Extremity Fragility Fractures (PRO HEAL Pilot)
Teriparatide
- NCT07265752Phase 2Not Yet Recruiting
Tirzepatide for the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07754045Phase 2Not Yet Recruiting
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
Semaglutide
- NCT07847515N/ANot Yet Recruiting
Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
Tirzepatide
- NCT07731256Phase 2Not Yet Recruiting
Semaglutide for Low Back Pain
Semaglutide
- NCT05714683N/ANot Yet Recruiting
Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Semaglutide
- NCT07803250Phase 1Not Yet Recruiting
Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery
BPC-157
- NCT07787936N/ANot Yet Recruiting
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
Tirzepatide
- NCT07622992N/ANot Yet Recruiting
Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
Tirzepatide
- NCT07858331Phase 4Not Yet Recruiting
Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
Semaglutide
- NCT06558422Phase 1Not Yet Recruiting
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Octreotide
- NCT07078838Phase 2Not Yet Recruiting
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
Tirzepatide
- NCT07829198Phase 3Not Yet Recruiting
Efficacy of Tirzepatide for Weight Management in Patients With Suboptimal Weight Loss After Bariatric Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Tirzepatide
- NCT07462663Phase 4Not Yet Recruiting
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
Semaglutide
- NCT07706361N/ANot Yet Recruiting
Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults
GHK-Cu
- NCT07859319Phase 4Not Yet Recruiting
Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting
Gonadorelin
- NCT07760948Phase 2Not Yet Recruiting
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide
Semaglutide
- NCT06180616Phase 2Not Yet Recruiting
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
Tirzepatide
- NCT07645326Phase 2Not Yet Recruiting
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Gonadorelin
- NCT07790861Phase 3Not Yet Recruiting
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
Orforglipron
- NCT07842172Phase 3Not Yet Recruiting
Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms
Octreotide
- NCT07468552Phase 2Not Yet Recruiting
Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07803705N/ANot Yet Recruiting
Efficacy of Mazdutide on Fatty Pancreas
Mazdutide
- NCT07855900Phase 3Not Yet Recruiting
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Survodutide
- NCT07796477Phase 2Not Yet Recruiting
A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin
Tirzepatide
- NCT07866066Phase 3Not Yet Recruiting
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
Semaglutide
- NCT07349641Phase 2Not Yet Recruiting
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
Tirzepatide
- NCT07812636EARLY_Phase 1Not Yet Recruiting
Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer
Tirzepatide
- NCT07609160N/ANot Yet Recruiting
Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
Tirzepatide
- NCT07832084Phase 4Not Yet Recruiting
Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s
Tirzepatide
- NCT07027969Phase 4Not Yet Recruiting
Metabolic Surgery for Atrial Fibrillation Elimination
Tirzepatide
- NCT06546384N/ANot Yet Recruiting
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
Semaglutide
- NCT07781150Phase 2Not Yet Recruiting
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
Mazdutide
- NCT07729332Phase 4Not Yet Recruiting
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
Orforglipron
- NCT07099742N/ANot Yet Recruiting
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
Tirzepatide
- NCT07850050Phase 3Not Yet Recruiting
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
Survodutide
- NCT07310420Phase 1Recruiting
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Gonadorelin
- NCT07850063Phase 3Not Yet Recruiting
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Survodutide
- NCT07840729Phase 1Not Yet Recruiting
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Semaglutide
- NCT06977438Phase 4Not Yet Recruiting
GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward
Semaglutide
- NCT07855315N/ANot Yet Recruiting
FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps
Desmopressin
- NCT07812597Phase 2Not Yet Recruiting
A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)
Semaglutide
- NCT07832799Phase 1Not Yet Recruiting
Comparing the Extent to Which Two Maridebart Cafraglutide Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
Maridebart-Cafraglutide
- NCT07627191EARLY_Phase 1Recruiting
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Semaglutide
- NCT07868354Phase 1Not Yet Recruiting
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
Tirzepatide
- NCT07866118N/ARecruiting
Thymalfasin for Immune Recovery in Adults With Sepsis
Thymosin-Alpha-1
- NCT07846865Phase 2/Phase 3Not Yet Recruiting
Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial
Tirzepatide